semaglutide side effects menstrual cycle Can Cause irregular Periods Understanding the Impact of Weight

eMed Population Health has been named a Novocare Recognized Care Provider by Novo Nordisk, enabling access to the newly FDA-approved Wegovy pillthe first and only oral GLP-1 approved for chronic weight management in adults

Up to 24.2% body weight reduction in 48 weeks (Phase 2, 12mg dose)

Originally approved to help with excess weight and obesity, the injectable Wegovy and its sibling-product Ozempic, which is for type 2 diabetes, have become synonymous with weight loss fads

Get Personalized Tirzepatide Weight Loss Treatment in Scottsdale, AZ to Support Appetite Control and Sustainable Weight Management.

Has Your Weight Loss Plateaued

Seventy-two week outcomes from the SURMOUNT-5 clinical trial have shown that tirzepatide (Zepbound) met the primary endpoint and all five key secondary endpoints, demonstrating superiority, compared to semaglutide (Wegovy) across the trial.The detailed results were presented at the 32nd European Congress on Obesity (ECO) and simultaneously published in The New England Journal of Medicine.SURMOUNT-5 was a 72-week, multi-centre, randomised, open-label, Phase 3b trial evaluating the efficacy and